These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16363277)

  • 1. [Malignancy and thrombosis: a double-sided clinical relationship].
    Luxembourg B; Bauersachs R
    Vasa; 2005 Nov; 34(4):225-34. PubMed ID: 16363277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and thrombosis: managing the risks and approaches to thromboprophylaxis.
    Hiller E
    Onkologie; 2006 Oct; 29(10):474-8. PubMed ID: 17028457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
    Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
    Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
    Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
    Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
    Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
    Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer-associated venous thromboembolic recurrence: disregard of treatment recommendations].
    Mahé I; Chidiac J
    Bull Cancer; 2014 Mar; 101(3):295-301. PubMed ID: 24691192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of deep-vein thrombosis with low-molecular-weight heparin: an update of the evidence.
    Hull RD; Townshend G
    Thromb Haemost; 2013 Jul; 110(1):14-22. PubMed ID: 23615656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal dosing of bemiparin as prophylaxis against venous thromboembolism in surgery for cancer: an audit of practice.
    Balibrea JL; Altimiras J; Larruzea I; Gómez-Outes A; Martínez-González J; Rocha E;
    Int J Surg; 2007 Apr; 5(2):114-9. PubMed ID: 17448976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism and cancer: risks and outcomes.
    Lee AY; Levine MN
    Circulation; 2003 Jun; 107(23 Suppl 1):I17-21. PubMed ID: 12814981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
    Khorana AA
    Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated venous thrombosis in the surgical setting.
    Behranwala KA; Williamson RC
    Ann Surg; 2009 Mar; 249(3):366-75. PubMed ID: 19247020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated thrombosis.
    Sood SL
    Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to improve the implementation of guidelines on cancer-related thrombosis.
    Debourdeau P; Beckers M; Gérôme P; Durant C; Lacoin Q; Debourdeau A; Bancel DF
    Expert Rev Anticancer Ther; 2011 Mar; 11(3):473-83. PubMed ID: 21417859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus location.
    Prestidge T; Lee S; Harper P; Young L; Ockelford P
    Intern Med J; 2012 Jan; 42(1):71-4. PubMed ID: 21118408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombosis in brain tumors.
    Jo JT; Schiff D; Perry JR
    Semin Thromb Hemost; 2014 Apr; 40(3):325-31. PubMed ID: 24599439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood coagulation changes and neoplastic pathology].
    Corsi MP; De Martinis M; Di Leonardo G; Loreto MF; Modesti M; Quaglino D
    Recenti Prog Med; 2000 Oct; 91(10):532-7. PubMed ID: 11072743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.
    Barsam SJ; Patel R; Arya R
    Br J Haematol; 2013 Jun; 161(6):764-77. PubMed ID: 23560605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.